iPhone | iPad
Android
Huawei
Omicron variant is highly contagious and can even infect vaccinated/infected people, say experts
KT APPDOWNLOAD
Covid-19: T-cells from common colds can provide protection against coronavirus, study shows
Internal proteins of the virus which are targeted by the T-cells could offer an alternative target for vaccine makers.
Reuters
High levels of T-cells from common cold coronaviruses can provide protection against Covid-19, an Imperial College London study published on Monday has found, which could inform approaches for second-generation vaccines.
Immunity against Covid-19 is a complex picture, and while there is evidence of waning antibody levels six months after vaccination, T-cells are also believed to play a vital role in providing protection.
The study, which began in September 2020, looked at levels of cross-reactive T-cells generated by previous common colds in 52 household contacts of positive Covid-19 cases shortly after exposure, to see if they went on to develop infection.
It found that the 26 who did not develop infection had significantly higher levels of those T-cells than people who did get infected. Imperial did not say how long protection from the T-cells would last.
"We found that high levels of pre-existing T cells, created by the body when infected with other human coronaviruses like the common cold, can protect against Covid-19 infection," study author Dr Rhia Kundu said.
The authors of the study, published in Nature Communications, said that the internal proteins of the SARS-CoV-2 virus which are targeted by the T-cells could offer an alternative target for vaccine makers.
Current Covid-19 vaccines target the spike protein, which mutates regularly, creating variants such as Omicron which lessen the efficacy of vaccines against symptomatic infection.
"In contrast, the internal proteins targeted by the protective T-cells we identified mutate much less," Professor Ajit Lalvani, co-author of the study, said.
ALSO READ:
"Consequently, they are highly conserved between the various SARS-CoV-2 variants, including Omicron. New vaccines that include these conserved, internal proteins would therefore induce broadly protective T cell responses that should protect against current and future SARS-CoV-2 variants."
More news from coronavirus
Doctors explain how some people can come into contact with a positive case without getting the virus themselves
Globally, cases decreased by nine per cent between July 25 and 31, as compared to the previous week
Over 178.2 million PCR tests have been conducted in the country so far
Total active cases stand at 18,841
Total active cases stand at 18,647
US President remains 'fever free and in good spirits'
Over 177.7 million PCR tests have been conducted in the country so far